Insider · CIK 0001572000

Lubner David Charles

Reports to the SEC for 11 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001572000

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-07	BRVEBraveheart Bio, Inc.P Purchase	Director	PPurchase	+55.6K sh	$18.00	+$1M	55,555
2026-08-05	BRVEBraveheart Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+60K sh	—	—	60,000
2026-06-05	DYNDyne Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+35.2K sh	—	—	35,152
2026-06-02	CBIOCRESCENT BIOPHARMA, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+11.1K sh	—	—	11,050
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−61.5K sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.6K sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,174 sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−31.8K sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,011 sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−59.4K sh	—	—	0
2026-04-28	Arcellx, Inc.U Disposition from Tender	Director	UDisposition from Tender	−21.7K sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.5K sh	—	—	0
2026-04-24	DYNDyne Therapeutics, Inc.G Gift	Director	GGift	−53.6K sh	—	—	0
2026-01-20	Arcellx, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	$6.28	+$37.7K	27,659
2026-01-20	Arcellx, Inc.S Sale	Director	SSale	−6,000 sh	$75.00	−$450K	21,659
2026-01-20	Arcellx, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	—	—	59,405
2025-08-19	CARGO Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2025-06-23	CBIOCRESCENT BIOPHARMA, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+9,023 sh	—	—	9,023
2025-06-18	CARGO Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2025-05-30	DYNDyne Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2025-05-29	Arcellx, Inc.Stock Option (right to buy)A Award	Director	AAward	+9,174 sh	—	—	9,174
2025-05-22	VORVor Biopharma Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-06-04	CARGO Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+23.7K sh	—	—	23,742
2024-05-28	Arcellx, Inc.Stock Option (right to buy)A Award	Director	AAward	+8,011 sh	—	—	8,011
2024-05-23	VORVor Biopharma Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-05-22	DYNDyne Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+25.1K sh	—	—	25,133
2023-12-27	POINT Biopharma Global Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−44.7K sh	—	—	0
2023-12-27	POINT Biopharma Global Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25.6K sh	—	—	0
2023-12-27	POINT Biopharma Global Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−3,600 sh	—	—	0
2023-12-27	POINT Biopharma Global Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2023-12-26	POINT Biopharma Global Inc.U Disposition from Tender	Director	UDisposition from Tender	−35.4K sh	—	—	3,600
2023-11-09	CARGO Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-06-14	Arcellx, Inc.Stock Option (right to buy)A Award	Director	AAward	+11.5K sh	—	—	11,459
2023-06-01	POINT Biopharma Global Inc.Stock Option (Right to Buy)A Award	Director	AAward	+44.7K sh	—	—	44,749
2023-05-26	VORVor Biopharma Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2023-05-24	DYNDyne Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+24.9K sh	—	—	24,900
2022-11-23	POINT Biopharma Global Inc.P Purchase	Director	PPurchase	+3,600 sh	$6.85	+$24.7K	3,600
2022-07-05	DYNDyne Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,222 sh	—	—	7,222
2022-06-14	VORVor Biopharma Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.9K sh	—	—	16,911
2022-06-03	DYNDyne Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19.6K sh	—	—	19,596
2022-06-02	POINT Biopharma Global Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25.6K sh	—	—	25,614
2022-02-08	Arcellx, Inc.C Conversion	Director	CConversion	+21.7K sh	—	—	21,659
2022-02-08	Arcellx, Inc.Series C Preferred StockC Conversion	Director	CConversion	−21.7K sh	—	—	0
2022-02-03	Arcellx, Inc.Stock Option (right to buy)A Award	Director	AAward	+61.5K sh	—	—	61,538
2021-10-04	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	0 sh	—	—	0
2021-10-04	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.2K sh	—	—	17,245
2021-07-06	POINT Biopharma Global Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2021-05-26	DYNDyne Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19.6K sh	—	—	19,596
2021-03-12	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2021-03-12	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,529

Recent filings

Accepted (ET)
Aug 74
Lubner David Charles0001470831-26-000796
SEC(opens sec.gov)
Jun 94
Lubner David Charles0001193125-26-264025
SEC(opens sec.gov)
Jun 34
Lubner David Charles0001628280-26-040582
SEC(opens sec.gov)
Apr 284
Lubner David Charles0001572000-26-000002
SEC(opens sec.gov)
Apr 284
Lubner David Charles0001193125-26-187601
SEC(opens sec.gov)
Jan 204
Lubner David Charles0001193125-26-017002
SEC(opens sec.gov)
Aug 194
Lubner David Charles0001610717-25-000303
SEC(opens sec.gov)
Jun 234
Lubner David Charles0001104659-25-061816
SEC(opens sec.gov)
Jun 204
Lubner David Charles0001610717-25-000245
SEC(opens sec.gov)
Jun 34
Lubner David Charles0000950170-25-081358
SEC(opens sec.gov)

Companies

Address

C/O BRAVEHEART BIO, INC. ONE LETTERMAN DR., BLDG. A, SUITE A4-300

SAN FRANCISCO, CA, 94129